Who owns INHIBRX BIOSCIENCES INC COM?
- Ticker: INBX
- CUSIP Number: 45720n103
Tip: Access positions for across all investors
Analyze quarterly positions in Inhibrx Biosciences with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Inhibrx Biosciences stock
Who bought or sold INHIBRX BIOSCIENCES INC COM this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Viking Global Investors | 1.8M | $28M | 0% | Sep 2024 |
|
| Perceptive Advisors | 1.1M | $17M | 0% | Sep 2024 |
|
| BlackRock | 717k | $11M | 100% | Sep 2024 |
|
| Walleye Trading Advisors | 550k | $8.6M | 16% | Sep 2024 |
|
| Sofinnova Ventures | 536k | $8.4M | 16% | Sep 2024 |
|
| Vanguard Group | 530k | $8.3M | 11% | Sep 2024 |
|
| Slotnik Capital | 369k | $5.8M | 8% | Sep 2024 |
|
| Millennium Management | 289k | $4.5M | -5% | Sep 2024 |
|
| Geode Capital Management | 251k | $3.9M | 19% | Sep 2024 |
|
| Caption Management | 200k | $3.1M | 0% | Sep 2024 |
|
| Kennedy Capital Management | 166k | $2.6M | 1% | Sep 2024 |
|
| State Street Corporation | 160k | $2.5M | 8% | Sep 2024 |
|
| Arrowpoint Asset Management | 157k | $2.5M | 3% | Sep 2024 |
|
| Susquehanna International | 149k | $2.3M | -6% | Sep 2024 |
|
| Schonfeld Strategic Advisors | 144k | $2.3M | 90% | Sep 2024 |
|
| CSS | 142k | $2.2M | -26% | Sep 2024 |
|
| Partner Fund Management | 136k | $2.1M | 0% | Sep 2024 |
|
| HighTower Advisors | 123k | $1.9M | 14% | Sep 2024 |
|
| Northern Trust | 113k | $1.8M | 100% | Sep 2024 |
|
| Qube Research & Technologies | 110k | $1.7M | -22% | Sep 2024 |
|
| Jane Street | 98k | $1.5M | -5% | Sep 2024 |
|
| Equitec Proprietary Markets | 96k | $1.5M | 3% | Sep 2024 |
|
| Marshall Wace | 91k | $1.4M | -54% | Sep 2024 |
|
| Russell Investments | 84k | $1.3M | 19% | Sep 2024 |
|
| Walleye Trading | 55k | $860k | -8% | Sep 2024 |
|
| Citadel Advisors | 54k | $852k | 100% | Sep 2024 |
|
| Acadian Asset Management | 54k | $846k | 100% | Sep 2024 |
|
| Ikarian Capital | 42k | $660k | -82% | Sep 2024 |
|
| GSA Capital Partners | 42k | $650k | 79% | Sep 2024 |
|
| Nuveen Asset Management | 41k | $640k | 97% | Sep 2024 |
|
| Yakira Capital Management | 36k | $567k | 100% | Sep 2024 |
|
| FMR | 36k | $556k | 26% | Sep 2024 |
|
| Murchinson | 34k | $529k | 95% | Sep 2024 |
|
| Wetherby Asset Management | 33k | $512k | 0% | Sep 2024 |
|
| Charles Schwab Investment Management | 33k | $511k | 22% | Sep 2024 |
|
| Birchview Capital | 32k | $503k | 165% | Sep 2024 |
|
| Boothbay Fund Management | 28k | $442k | -65% | Sep 2024 |
|
| Fort Hoosac Management | 28k | $440k | 100% | Sep 2024 |
|
| Bank of New York Mellon | 26k | $403k | -18% | Sep 2024 |
|
| Pekin, Singer Strauss Asset Management | 26k | $400k | 100% | Sep 2024 |
|
| Renaissance Technologies | 25k | $393k | 100% | Sep 2024 |
|
| Empirical Financial Services, LLC d/b/a Empirical Wealth Management | 23k | $348k | 100% | Dec 2024 |
|
| Goldman Sachs Group | 22k | $341k | 100% | Sep 2024 |
|
| Squarepoint Ops | 21k | $330k | 100% | Sep 2024 |
|
| JBF Capital | 21k | $328k | 0% | Sep 2024 |
|
| Jacobs Levy Equity Management | 21k | $321k | 100% | Sep 2024 |
|
| Bluefin Capital Management | 19k | $289k | -44% | Sep 2024 |
|
| Alliancebernstein | 18k | $281k | -7% | Sep 2024 |
|
| Barclays | 16k | $252k | 349% | Sep 2024 |
|
| CI Private Wealth | 14k | $217k | 100% | Sep 2024 |
|
| Rhumbline Advisers | 14k | $216k | -2% | Sep 2024 |
|
| AQR Capital Management | 13k | $204k | 100% | Sep 2024 |
|
| ALPS Advisors | 11k | $172k | 100% | Sep 2024 |
|
| Bank of America Corporation | 10k | $159k | 2% | Sep 2024 |
|
| Exchange Traded Concepts | 9.6k | $148k | 100% | Dec 2024 |
|
| Citigroup | 9.3k | $146k | 122% | Sep 2024 |
|
| Bnp Paribas Arbitrage, Snc | 7.8k | $122k | 604% | Sep 2024 |
|
| UBS Group | 6.0k | $95k | 88% | Sep 2024 |
|
| MetLife Investment Advisors | 5.9k | $92k | 21% | Sep 2024 |
|
| Mirae Asset Global Etfs Holdings | 5.7k | $89k | 17% | Sep 2024 |
|
| Jpmorgan Chase & Co | 5.1k | $80k | -88% | Sep 2024 |
|
| Wells Fargo & Company | 5.0k | $78k | 10% | Sep 2024 |
|
| New York State Common Retirement Fund | 3.5k | $54k | 0% | Sep 2024 |
|
| China Universal Asset Management | 3.1k | $47k | 100% | Dec 2024 |
|
| Us Bancorp | 2.3k | $36k | 1768% | Sep 2024 |
|
| Erste Asset Management GmbH | 2.2k | $34k | 0% | Sep 2024 |
|
| Simplex Trading | 2.2k | $33k | 100% | Sep 2024 |
|
| Natixis | 2.0k | $31k | 0% | Sep 2024 |
|
| OTR - Nominee Name for The State Teachers Retirement Board of Ohio | 1.9k | $30k | 0% | Sep 2024 |
|
| Royal Bank of Canada | 1.9k | $27k | 74% | Sep 2024 |
|
| Covestor | 1.7k | $26k | 100% | Sep 2024 |
|
| Legal & General Group | 1.0k | $16k | -77% | Sep 2024 |
|
| Pnc Financial Services | 946.00 | $15k | 21% | Sep 2024 |
|
| Tower Research Capital | 893.00 | $14k | -69% | Sep 2024 |
|
| California State Teachers Retirement System | 858.00 | $13k | 13% | Sep 2024 |
|
| Summit Investment Advisors | 853.00 | $13k | 0% | Sep 2024 |
|
| Larson Financial Group | 581.00 | $9.1k | 100% | Sep 2024 |
|
| NISA Investment Advisors | 568.00 | $8.7k | 11% | Dec 2024 |
|
| CWM | 549.00 | $9.0k | 100% | Sep 2024 |
|
| Mirae Asset Global Investments | 482.00 | $7.2k | 100% | Dec 2024 |
|
| Amalgamated Bank | 362.00 | $6.0k | 0% | Sep 2024 |
|
| FNY Investment Advisers | 250.00 | $3.0k | 69% | Dec 2024 |
|
| Nelson, Van Denburg & Campbell Wealth Management | 248.00 | $3.8k | -23% | Dec 2024 |
|
| Signature | 186.00 | $2.9k | 0% | Sep 2024 |
|
| Quadrant Capital | 171.00 | $2.7k | 0% | Sep 2024 |
|
| Group One Trading | 144.00 | $2.3k | 0% | Sep 2024 |
|
| Deutsche Bank Aktiengesellschaft | 122.00 | $1.9k | 0% | Sep 2024 |
|
| Zurcher Kantonalbank | 118.00 | $1.8k | 0% | Sep 2024 |
|
| Huntington National Bank | 90.00 | $1.4k | 100% | Sep 2024 |
|
| Advisor Group Holdings | 85.00 | $1.3k | 100% | Sep 2024 |
|
| GAMMA Investing | 69.00 | $1.1k | -52% | Dec 2024 |
|
| Capital Performance Advisors | 61.00 | $954.997700 | 100% | Sep 2024 |
|
| True Wealth Design | 47.00 | $737.002300 | 100% | Sep 2024 |
|
| Lindbrook Capital | 17.00 | $266.000700 | 0% | Sep 2024 |
|
| Bessemer | 12.00 | $0 | 100% | Sep 2024 |
|
| SRS Capital Advisors | 10.00 | $157.000000 | 0% | Sep 2024 |
|
| Sterling Capital Management | 6.00 | $94.000200 | 100% | Sep 2024 |
|
| EverSource Wealth Advisors | 6.00 | $94.000200 | 0% | Sep 2024 |
|
| Quest Partners | 3.00 | $47.000100 | 0% | Sep 2024 |
|
| Farther Finance Advisors | 2.00 | $31.000000 | 0% | Sep 2024 |
|
| Rothschild Investment | 2.00 | $31.000000 | -33% | Sep 2024 |
|
Who sold out of Inhibrx Biosciences?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Alpine Associates Management | Jun 2024 | 306k | $4.3M |
| TIG Advisors | Jun 2024 | 244k | $3.5M |
| Tang Capital Management | Jun 2024 | 168k | $2.4M |
| MMCAP International Inc. SPC | Jun 2024 | 113k | $1.6M |
| Soleus Capital Management | Jun 2024 | 89k | $1.3M |
| Westchester Capital Management | Jun 2024 | 64k | $912k |
| Wellington Management Company | Jun 2024 | 32k | $449k |
| Franklin Resources | Jun 2024 | 23k | $320k |
| Invesco | Jun 2024 | 21k | $303k |
| Cantor Fitzgerald, L. P. | Jun 2024 | 18k | $259k |
| Alpine Partners VI | Jun 2024 | 12k | $176k |